Pulling SEC filings + quote and writing the call…

Sanofi
Next earnings Jul 30, 2026 · consensus $1.89 EPS, $11.4B rev
Mixed signals in the latest filings.
Sanofi shows limited reported revenue.
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001121404, latest 6-K filed 2026-06-24) · EODHD · as of 6/20/2026, 7:11:18 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2021-09-14 | Sanofi 10% owner | Buy | 51.5M @ $38.00 | $1.96B |
| 2021-09-14 | Sanofi 10% owner | Buy | 20.5M @ $38.00 | $780M |
| 2021-08-02 | Sanofi 10% owner | Acquired (C) | 3.09M | |
| 2021-08-02 | Sanofi 10% owner | Buy | 66.7K @ $15.00 | $1.00M |
| 2020-07-28 | Sanofi 10% owner | Acquired (C) | 439K | |
| 2020-07-28 | Sanofi 10% owner | Buy | 81.3K @ $16.00 | $1.30M |
| 2020-06-09 | Sanofi 10% owner | Sell | 120K @ $597.48 | $71.8M |
| 2020-05-29 | Sanofi 10% owner | Sell | 20.4M @ $509.85 | $10.4B |
| 2020-05-29 | Sanofi 10% owner | Sell | 2.40M @ $509.85 | $1.22B |
| 2020-03-09 | Sanofi 10% owner | Sell | 129K @ $489.65 | $63.1M |
| 2019-09-10 | Sanofi 10% owner | Sell | 173K @ $281.15 | $48.6M |
| 2019-07-22 | Sanofi 10% owner | Acquired (C) | 464K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.